Article Preview
TopIntroduction
The use of electronic Prescription and Patient Summary services (eP/ PS) has been recognized as an important strategic policy to improve health care across Europe and to support access to safe and high-quality, cross-border healthcare (Tinholt et al., 2013). Electronic prescribing has already proved that can help patients by providing easier prescription and medication pick-up procedures, fewer difficulties over prescription insurance coverage and an increase in patient safety (e.g. by checking legible prescriptions for harmful interactions) (Hollingworth et al., 2007; Wang et al., 2009). Key benefits of ePrescription (eP) have been identified as improving the quality of health care services, increasing the efficiency and effectiveness of prescribing and dispensing medications, reducing medication errors, and health care cost savings (Pangalos et al., 2013). It is important to note that failure to properly implement eP systems can result in new types of errors that can reduce workflow efficiency, increase medication cost, and threaten patient safety (Zadeh & Tremblay, 2016). At the same time, during the past few years many regional and national healthcare networks have been deployed in Europe to support Patient Summary (PS) and Electronic Health Record (EHR) solutions (Stroetmann et al., 2011). The gains from EHR systems depend on meaningful sharing and rely on access to information regardless of place and time, and from re-using information for multiple purposes (Dobrev et al., 2010; Prey et al., 2016).
The deployment of eHealth solutions for eP/ PS is expected to increase safety and quality of care throughout the European Union and associated countries (EU), by ensuring continuity of care across borders and by providing immediate clinical information needed in an emergency situation abroad. Greater knowledge of patients’ clinical characteristics and treatment is expected to improve clinical decision making (Moharra et al., 2015). It is a fact that despite favourable attitudes towards both cross-border eP/ PS, multiple perceived barriers impede their incorporation and integration in clinical practice. Infrastructures are not in place to support the system and stakeholders in some jurisdictions are reluctant to embrace eHealth due to the high cost and the lack of security of the systems (Kierkegaard, 2013). Patient identification and consent processes are currently laborious and somewhat time consuming, and member states have varying degrees of health care policy, privacy enforcement and laws concerning data protection (DG Santé, 2014). In most of the cases integration with national, health service Information Technology (IT) systems is still missing.